.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Queensland Health
Cerilliant
Mallinckrodt
UBS
Daiichi Sankyo
McKesson
Argus Health
Johnson and Johnson
McKinsey

Generated: January 16, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Australia Patent: PO9838

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Mylan Pharms IncEXTINAketoconazoleAEROSOL, FOAM;TOPICAL021738-001Jun 12, 2007ATRXYesYes➤ Subscribe➤ SubscribeYTOPICAL TREATMENT OF SEBORRHEIC DERMATITIS IN IMMUNOCOMPETETENT PATIENTS 12 YEARS OF AGE AND OLDER
Mylan Pharms IncEXTINAketoconazoleAEROSOL, FOAM;TOPICAL021738-001Jun 12, 2007ATRXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF SEBORRHEA DERMATITIS IN HUMANS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist